Itamar Medical Ltd

(PINK:ITMMF)

Latest On Itamar Medical Ltd (ITMMF):

Date/Time Type Description Signal Details
2021-03-04 14:05 ESTFinancialsCompany financials have been released.Neutral
2020-12-04 06:22 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:38 ESTFinancialsCompany financials have been released.Neutral
2020-11-19 15:35 ESTFinancialsCompany financials have been released.Neutral
2020-10-08 20:59 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:21 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:34 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:13 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:39 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 11:28 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 16:21 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 19:37 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 12:01 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 04:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 20:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 08:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 00:44 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 16:15 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 16:18 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 21:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 12:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 07:28 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 23:32 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 20:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 04:00 ESTFinancialsCompany financials have been released.Neutral
2020-06-25 07:22 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 15:59 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 08:11 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 09:44 ESTFinancialsCompany financials have been released.Neutral
2020-06-07 19:44 ESTFinancialsCompany financials have been released.Neutral
2020-06-05 15:31 ESTFinancialsCompany financials have been released.Neutral
2020-06-03 19:22 ESTFinancialsCompany financials have been released.Neutral
2020-05-29 03:13 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 14:37 ESTNewsItamar Medical Ltd. 2020 Q1 - Results - Earnings Call PresentationN/A
2020-05-27 08:48 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 04:34 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 03:49 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 11:32 ESTFinancialsCompany financials have been released.Neutral
2020-05-07 03:50 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 09:12 ESTFinancialsCompany financials have been released.Neutral
2020-05-02 23:39 ESTFinancialsCompany financials have been released.Neutral
2020-05-02 02:14 ESTNewsItamar Medical Ltd. 2019 Q4 - Results - Earnings Call PresentationN/A
2020-05-01 19:58 ESTFinancialsCompany financials have been released.Neutral
2020-04-30 07:27 ESTFinancialsCompany financials have been released.Neutral

About Itamar Medical Ltd (ITMMF):

Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.

See Advanced Chart

General

  • Name Itamar Medical Ltd
  • Symbol ITMMF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Fiscal Year EndDecember
  • Web URLhttp://www.itamar-medical.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 8.18
  • Price/Book (Most Recent Quarter) 9.21
  • Enterprise Value Revenue 8.81
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin -27%
  • Operating Margin -25%
  • Return on Assets -13%
  • Return on Equity -37%
  • Revenue 41.03 million
  • Earnings Per Share -$0.02
  • Revenue Per Share $0.1
  • Gross Profit 28.71 million
  • Quarterly Earnings Growth 30.8%
View More

Highlights

  • Market Capitalization 389.67 million
  • EBITDA -3547000
  • Book Value Per Share $0.10
View More

Share Statistics

  • Shares Outstanding 491.43 million
  • Shares Float 301.33 million
  • % Held by Insiders 1691%
  • % Held by Institutions 18.26%
View More

Technicals

  • Beta 0.63
  • 52 Week High $1
  • 52 Week Low $0.3
  • 50 Day Moving Average 0.85
  • 200 Day Moving Average 0.74
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Itamar Medical Ltd (ITMMF) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Itamar Medical Ltd (ITMMF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31$12.77 million-$0.01
2020-09-302020-12-31$11 million-$0.01
2020-06-302020-09-30$8.89 million-$0.01
2020-03-312020-06-30$8.38 million-$0.01
2019-12-312020-03-31$9.77 million-$0.01
2019-09-302019-12-31$8.08 million$-0.00
2019-06-302019-09-30$7.35 million$-0.00
2019-03-312019-06-30$6.06 million-$0.01
2018-12-312018-12-31$6.58 million$-0.00
2018-09-302018-12-31$6.06 million$-0.00
2018-06-302018-09-30$6.08 million-$0.01
2018-03-312018-03-31$5.47 million$0.00
2017-12-312017-12-31$6.02 million-$0.01
2017-09-302017-12-31$5.28 million-$0.02
2017-06-302017-09-30$5.06 million$-0.00
2017-03-312017-03-31$4.35 million-$0.01
2016-12-312016-12-31$4.96 million$0.01
2016-09-302016-12-31$0.01
2016-06-302016-09-30-$0.02
2016-03-312016-06-30-$0.02
2015-12-312016-03-31-$0.02$0.00
2015-09-302015-12-31-$0.01$0.00
2015-06-302015-09-30$0.00
2015-03-312015-06-30-$0.01$0.00
2014-12-312015-03-31-$0.01$0.00
2014-09-302014-12-31-$0.02$0.00
2014-06-302014-09-30$0.03
2014-03-312014-06-30$-0.00$0.00
2013-12-312014-03-31-$0.04$0.00
2013-09-302013-12-31-$0.10$0.00
2013-06-302013-09-30-$0.01$0.00
2013-03-312013-06-30-$0.01$0.00
2012-12-312013-03-31-$0.01$0.00
2012-09-302012-12-31$-0.00$0.00
2012-06-302012-09-30$-0.00$0.00
2012-03-312012-06-30$0.00$0.00
2011-09-302011-12-31$-0.00$0.00
2011-06-302011-09-30$0.01$0.00
2011-03-312011-06-30-$0.01$0.00
2010-12-312011-03-31-$0.01$0.00
2010-09-302010-12-31$0.00$0.00

Itamar Medical Ltd (ITMMF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 1.94 million 1.39 million 1.38 million 1.3 million 1.36 million
Income Before Tax -2.96 million -2.66 million -3.23 million -1.96 million -1.1 million
Selling General Administrative 9.56 million 8.66 million 7.86 million 6.98 million 7.17 million
Gross Profit 8.84 million 7.53 million 6.02 million 6.33 million 7.65 million
Ebit -1.87 million -1.92 million -2.59 million -1.31 million -1.32 million
Operating Income -2.66 million -2.51 million -3.22 million -1.96 million -877000
Income Tax Expense N/A 95000 10000 N/A -98000
Total Revenue 12.77 million 11 million 8.89 million 8.38 million 9.77 million
Cost of Revenue 3.93 million 3.47 million 2.87 million 2.05 million 2.12 million
Total Other Income Expense Net N/A N/A N/A N/A -158000
Net Income From Continuing Operations -2.94 million -2.76 million -3.24 million -2 million -999000
Net Income Applicable to Common Shares N/A -2.76 million -3.24 million N/A -999000
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A -231000 8.86 million -212000
Change to Liabilities 782000 151000 N/A -187000 199000
Total Cash Flow from Investing Activities -9.4 million -8.03 million N/A 8.86 million -212000
Net Borrowings -220000 -220000 N/A -204000 -144000
Total Cash Flow from Financial Activities N/A N/A 36.84 million -116000 -146000
Change to Operating Activities 979000 336000 N/A 1.14 million 192000
Change in Cash N/A N/A 35.2 million 6.67 million -633000
Total Cash from Operating Activities -2.91 million -3.74 million -1.41 million -2.08 million -275000
Depreciation N/A N/A 410000 387000 385000
Other Cash Flow from Investing Activities N/A N/A N/A N/A -68000
Change to Inventory N/A N/A -761000 -426000 -633000
Change to Account Receivables N/A N/A 1.18 million -2.43 million 388000
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 460000 315000 N/A 438000 341000
Capital Expenditures N/A N/A 231000 141000 144000
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 21.07 million 18.03 million N/A 16.02 million 16.54 million
Total Stockholder Equity 43.07 million 46.04 million N/A 51.64 million 16.66 million
Other Current Liabilities N/A 3.9 million N/A N/A 3.73 million
Total Assets 64.14 million 64.07 million N/A 67.66 million 33.21 million
Common Stock N/A 1.14 million 1.13 million N/A 878000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -119.07 million -116.56 million -114.16 million -111.22 million -109.65 million
Other Liabilities N/A 1.48 million 1.47 million N/A 1.52 million
Other Assets N/A 912000 782000 N/A 909000
Cash 9.67 million 25.15 million N/A 50.44 million 15.12 million
Total Current Liabilities 17.99 million 15.41 million N/A 13.12 million 13.32 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment N/A 4.37 million 3.89 million N/A 3.91 million
Total Current Assets 57.44 million 57.94 million N/A 62.64 million 28.27 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets N/A 45.18 million 47.7 million N/A 16.55 million
Short Term Investments 30 million 16 million N/A N/A N/A
Long Term Debt 154000 N/A N/A N/A N/A
Inventory 7.16 million 6.48 million N/A 3.91 million 3.36 million
Accounts Payable 4.42 million 3.39 million N/A 2.97 million 2.03 million

Itamar Medical Ltd (ITMMF) Chart:

Itamar Medical Ltd (ITMMF) News:

Below you will find a list of latest news for Itamar Medical Ltd (ITMMF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Itamar Medical Ltd (ITMMF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Itamar Medical Ltd (ITMMF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link